Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Industry pharmaceutical

Fine Chemicals The Industry and the Business, by Peter Poliak Copyright 2007 by John Wiley Sons, Inc. [Pg.93]

Big pharma 20 Global companies with sales 5 billion many blockbusters, large in-house capabilities in R D, manufacturing marketing See Table 11.2 [Pg.94]

Medium pharma 50-100 Sales 0.5- 5 billion, regional reach, 300 m reactor volume, limited R D capabilities, mainly unlicensed drugs and generics. Barr, Forest, Sepracor, USA Altana, Merck, Stada, Germany Sankyo, Japan Dr Reddy s, Ranbaxy, India [Pg.94]

Virtual pharma 4000- 5000 Venture capital funded, 1-2 developmental drugs, mainly biopharmaceuticals, small R D, no production, no M S organization Cell Therapeutics, Gilead, Trimeris, Vertex, USA Alizyme, UK Morphosys, Germany Actelion, Speedel, Switzerland [Pg.94]

Some big and medium pharma companies are hybrids in the sense that they also offer pharmaceutical fine chemicals and custom manufacturing services and therefore compete with their PFC suppliers. [Pg.95]

However it is essential, in an industrial context, to have traceable and validated bases for the determination of target parameters whatever the experimental technique used. Microcalorimetry is no exception and a standard test and reference reaction has been described that fulfils this need. The imidazole-catalysed hydrolysis of triacetin has, as a result of an international multi-laboratory study, been selected as this test and [Pg.104]

Calorimetric techniques have been applied across the range of issues concerned with drug development from lead discovery to formulated medicine and in aspects of this process - discovery, characterisation, formulation development, process development and scaleup - that are the subject of this chapter. As most studies have been concerned with stability and compatibility issues, it seems logical to consider these applications in almost reverse order. [Pg.105]

Conventionally, stability testing is performed in an accelerated reaction regime i.e. at elevated temperatures ( 323 K) and at controlled humidity (say 70% RH). Derived reaction rate constants are used to predict, through application of the Arrhenius equation, the rate constant at the proposed storage conditions of the medicine. This extrapolation depends on the constancy of the reaction mechanism over the temperature range concerned. It would clearly be better to have direct determination of reaction rate constants under the storage environmental conditions. [Pg.105]

Until around 1995, it was unusual to find kinetic data determined from isothermal microcalorimetric studies - and this was especially true for long, slow reaction systems. However, the modem microcalorimeter has excellent long-term stability (1 /xW or better over 24 h) and hence slow reactions can readily be investigated even those for which a complete reaction is not observed. Willson et al. showed that quantitative kinetic and thermodynamic data could be determined for reactions that had half lives of up to 2500 years. Commencing with a conventional (here simple for clarity) rate expression such as [Pg.105]

It is this calorimetric form of this equation (and the more complex equations that can be developed and used to describe sequential, parallel and more complex reacting systems) that can be analysed to yield values for the target parameters, n, k, H, K, G, S and E. References 6 and 7 provide details on the derivation of calorimetric kinetic equations and describe how to manipulate calorimetric data to determine equilibrium constants, Gibbs functions, entropies and activation energies. The approach described shows that, under normal storage conditions ( room temperature i.e. 298 K and ambient humidity), it is possible, from only 50 h of power time (the calorimetric output is of W vs. t) data, through these techniques, to distinguish between a [Pg.105]

The word pyrogen means fever-producing and has been used to cover any substance which causes a body temperature increase on injection. In fact, the first compendial pyrogen test was published in the 1942 edition of the United States Pharmacopeia. It involved the measurement of the rise of body temperature in rabbits upon intravenous injection of a test product. More recently (1977), the FDA approved the Limulus amebocyte lysate (LAL) test which can be run for less than 10% of the cost of a rabbit test. [Pg.221]

Because of their fever-producing capability, pyrogens must be barred entrance to the blood stream, particularly in persons who are ill or whose immune systems are weaker than normal. It is well known that pyrogens can produce shock and even death.47 [Pg.221]

In the early years of process development, chemistry, variables were optimized sequentially and through multiple loops. The variables are rarely independent, and this is a slow and inefficient process. More modern work optimizes variables simultaneously, using multiple parallel experiments with computer analysis of the outcomes. [Pg.1150]

In the few pages available here, it s impossible to do justice to the modern pharmaceutical industry its social and economic importance cannot be overestimated. Until the mid-nineteenth century, most medicinal compounds were herbal remedies. Many of these traditional medicines were successful, and their descendants are still widely used. Aspirin, 24.1, is derived from salicylic acid (24.2) in willow bark (Latin, salix, willow tree), and willow bark preparations have been known to have analgesic effects since the Paleolithic. The narcotic effects of [Pg.1150]


Steel framed buildings Steel bridges Fertilizer factories Oil refineries Chemical industries Pharmaceutical industries Machinery parts... [Pg.918]

Chetnoinformatics has matured to a sdentific discipline that will change - and in some cases has already changed - the way in which we perceive chemistry. The chemical and, in particular, the pharmaceutical industry are in high need of che-moinformatics specialists. Thus, this field has to be taught in academia, both in specialized courses on chemoinformatics and by integrating chemoinformatics into regular chemistry curricula. [Pg.13]

The cutoff values of this Rtile of Five the thresholds are a multiple of five) differ slightly within the pharmaceutical industry. Sometimes the Rule of Five" is extended by a fifth condition ... [Pg.607]

Foremost we hope - and believe - that chemoinformatics will become of increasing importance in the teaching of chemistry. The instruments and methods that are used in chemistry will continue to swamp us with data and we have to manage these data to increase our chemical knowledge. We have to understand more deeply, and exploit, the results of our experiments. Concomitantly, demands on the properties of the compounds that are produced by the chemical and pharmaceutical industries will continue to rise. We will need materials that are better we need them to be more selective, have fewer undesirable properties, able to be broken down easily in the environment without producing toxic by-products, and so on. This asks for more insight into the relationships between chemical structures and their properties. Furthermore, we have to plan and perform fewer and more efficient experiments. [Pg.623]

In order to parameterize a QSAR equation, a quantihed activity for a set of compounds must be known. These are called lead compounds, at least in the pharmaceutical industry. Typically, test results are available for only a small number of compounds. Because of this, it can be difficult to choose a number of descriptors that will give useful results without htting to anomalies in the test set. Three to hve lead compounds per descriptor in the QSAR equation are normally considered an adequate number. If two descriptors are nearly col-linear with one another, then one should be omitted even though it may have a large correlation coefficient. [Pg.247]

The pharmaceutical industry has developed and studied a number of anabolic steroids for use in vet erinary medicine and in rehabilitation from injuries that are accompanied by deterioration of muscles The ideal agent would be one that possessed the an abolic properties of testosterone without its andro genic (masculinizing) effects Methandrostenolone (Dianabol) and stanozolol are among the many syn thetic anabolic steroids that require a prescription... [Pg.1099]

Memfield s concept of a solid phase method for peptide synthesis and his devel opment of methods for carrying it out set the stage for an entirely new way to do chem ical reactions Solid phase synthesis has been extended to include numerous other classes of compounds and has helped spawn a whole new field called combinatorial chemistry Combinatorial synthesis allows a chemist using solid phase techniques to prepare hun dreds of related compounds (called libraries) at a time It is one of the most active areas of organic synthesis especially m the pharmaceutical industry... [Pg.1142]

HPLC is routinely used for both qualitative and quantitative analyses of environmental, pharmaceutical, industrial, forensic, clinical, and consumer product samples. Figure 12.30 shows several representative examples. [Pg.586]

Polymeric resins [81133-25-7], widely used in the food and pharmaceutical industries as cation—anion exchangers for the... [Pg.292]

The behavior of drops in the centrifugal field has been studied (211) and the residence times and mass-transfer rates have been measured (212). PodbieHiiak extractors have been widely used in the pharmaceutical industry, eg, for the extraction of penicillin, and are increasingly used in other fields as weU. Commercial units having throughputs of up to 98 m /h (26,000 gal/h) have been reported. [Pg.77]

Pharmaceutical Processes. The pharmaceutical industry is a principal user of extraction because many pharmaceutical intermediates and products ate heat-sensitive and cannot be processed by methods such as distillation. A usehil broad review can be found in the Hterature (241). [Pg.79]

The combined pharmaceutical appHcations account for an estimated 25% of DMF consumption. In the pharmaceutical industry, DMF is used in many processes as a reaction and crystallizing solvent because of its remarkable solvent properties. For example, hydrocortisone acetate [50-03-3] dihydrostreptomycin sulfate [5490-27-7] and amphotericin A [1405-32-9] are pharmaceutical products whose crystallization is faciHtated by the use of DMF. Itis also a good solvent for the fungicide griseofulvin/72%(97-< 7 and is used in its production. [Pg.514]

Full details of this work were pubHshed (6) and the processes, or variants of them, were introduced in a number of other countries. In the United States, the pharmaceutical industry continued to provide manufacturing sites, treating plasma fractionation as a normal commercial activity. In many other countries processing was undertaken by the Red Cross or blood transfusion services that emerged following Wodd War II. In these organisations plasma fractionation was part of a larger operation to provide whole blood, blood components, and speciaUst medical services on a national basis. These different approaches resulted in the development of two distinct sectors in the plasma fractionation industry ie, a commercial or for-profit sector based on paid donors and a noncommercial or not-for-profit sector based on unpaid donors. [Pg.526]

The majority of the imported gum karaya is used by the pharmaceutical industry as a bulk laxative, in dental adhesives, and in sealing gaskets for colostomy bags. [Pg.434]

BRS Online Products. This vendor comprises BRS Online Service, BRS/Colleague, BRS/After Dark, and BRS/Morning Search (35). The strength of BRS is in medical, physical, and social sciences as well as business and news databases of value to the health care and pharmaceutical industries... [Pg.114]

The number of microencapsulated commercial oral formulations available and the volume of these formulations sold annuaUy is comparatively smaU. This may reflect the difficulty of developing new dmg formulations and bringing them successfully to market or the fact that existing microencapsulation techniques have had difficulty economically producing mictocapsules that meet the strict performance requirements of the pharmaceutical industry. One appHcation that is a particularly active area of development is mictocapsules or microspheres for oral deUvery of vaccines (45,46). [Pg.324]


See other pages where Industry pharmaceutical is mentioned: [Pg.197]    [Pg.433]    [Pg.129]    [Pg.98]    [Pg.602]    [Pg.655]    [Pg.656]    [Pg.187]    [Pg.151]    [Pg.644]    [Pg.526]    [Pg.743]    [Pg.1043]    [Pg.60]    [Pg.80]    [Pg.405]    [Pg.436]    [Pg.442]    [Pg.442]    [Pg.55]    [Pg.538]    [Pg.207]    [Pg.208]    [Pg.397]    [Pg.434]    [Pg.176]    [Pg.451]    [Pg.201]    [Pg.516]    [Pg.358]    [Pg.468]    [Pg.546]    [Pg.547]    [Pg.88]    [Pg.324]   
See also in sourсe #XX -- [ Pg.77 , Pg.78 ]

See also in sourсe #XX -- [ Pg.67 , Pg.69 , Pg.132 , Pg.154 , Pg.158 , Pg.210 , Pg.230 , Pg.248 , Pg.251 , Pg.437 , Pg.439 , Pg.440 , Pg.474 , Pg.772 ]

See also in sourсe #XX -- [ Pg.91 ]

See also in sourсe #XX -- [ Pg.263 , Pg.356 ]

See also in sourсe #XX -- [ Pg.436 ]

See also in sourсe #XX -- [ Pg.84 ]

See also in sourсe #XX -- [ Pg.602 ]

See also in sourсe #XX -- [ Pg.123 , Pg.137 , Pg.209 ]

See also in sourсe #XX -- [ Pg.70 ]

See also in sourсe #XX -- [ Pg.136 , Pg.151 ]

See also in sourсe #XX -- [ Pg.14 , Pg.45 , Pg.116 , Pg.141 , Pg.142 , Pg.241 , Pg.251 ]

See also in sourсe #XX -- [ Pg.4 , Pg.8 , Pg.48 , Pg.50 ]

See also in sourсe #XX -- [ Pg.28 ]

See also in sourсe #XX -- [ Pg.188 ]

See also in sourсe #XX -- [ Pg.280 ]

See also in sourсe #XX -- [ Pg.65 ]

See also in sourсe #XX -- [ Pg.11 , Pg.13 , Pg.55 , Pg.56 , Pg.57 , Pg.58 , Pg.59 , Pg.60 , Pg.61 , Pg.64 , Pg.88 , Pg.155 , Pg.214 , Pg.217 ]

See also in sourсe #XX -- [ Pg.8 , Pg.260 , Pg.274 ]

See also in sourсe #XX -- [ Pg.634 ]

See also in sourсe #XX -- [ Pg.254 ]

See also in sourсe #XX -- [ Pg.12 , Pg.13 ]

See also in sourсe #XX -- [ Pg.2783 , Pg.3419 ]

See also in sourсe #XX -- [ Pg.657 ]

See also in sourсe #XX -- [ Pg.104 ]

See also in sourсe #XX -- [ Pg.232 ]

See also in sourсe #XX -- [ Pg.3 ]

See also in sourсe #XX -- [ Pg.538 , Pg.548 , Pg.726 ]

See also in sourсe #XX -- [ Pg.85 , Pg.126 , Pg.178 , Pg.181 , Pg.195 , Pg.226 , Pg.363 , Pg.383 , Pg.406 ]

See also in sourсe #XX -- [ Pg.144 ]

See also in sourсe #XX -- [ Pg.107 ]

See also in sourсe #XX -- [ Pg.127 , Pg.211 , Pg.222 , Pg.903 , Pg.904 , Pg.907 , Pg.909 , Pg.911 ]

See also in sourсe #XX -- [ Pg.282 , Pg.295 , Pg.308 , Pg.311 ]

See also in sourсe #XX -- [ Pg.572 ]

See also in sourсe #XX -- [ Pg.6 , Pg.7 ]

See also in sourсe #XX -- [ Pg.5 ]

See also in sourсe #XX -- [ Pg.270 ]

See also in sourсe #XX -- [ Pg.47 , Pg.49 , Pg.50 , Pg.387 ]

See also in sourсe #XX -- [ Pg.9 , Pg.48 , Pg.83 ]

See also in sourсe #XX -- [ Pg.13 ]

See also in sourсe #XX -- [ Pg.22 , Pg.28 , Pg.32 , Pg.73 , Pg.276 , Pg.295 , Pg.307 , Pg.310 , Pg.333 , Pg.334 ]

See also in sourсe #XX -- [ Pg.85 , Pg.98 ]

See also in sourсe #XX -- [ Pg.118 , Pg.240 ]

See also in sourсe #XX -- [ Pg.127 , Pg.211 , Pg.222 , Pg.903 , Pg.904 , Pg.907 , Pg.909 , Pg.911 ]

See also in sourсe #XX -- [ Pg.26 ]

See also in sourсe #XX -- [ Pg.220 , Pg.222 , Pg.310 ]

See also in sourсe #XX -- [ Pg.327 , Pg.375 ]

See also in sourсe #XX -- [ Pg.1468 ]

See also in sourсe #XX -- [ Pg.84 , Pg.122 , Pg.162 , Pg.175 , Pg.203 ]

See also in sourсe #XX -- [ Pg.1468 ]

See also in sourсe #XX -- [ Pg.2 , Pg.11 , Pg.141 ]

See also in sourсe #XX -- [ Pg.208 , Pg.755 , Pg.1041 , Pg.1042 , Pg.1043 , Pg.1044 , Pg.1045 , Pg.1046 , Pg.1047 , Pg.1048 , Pg.1049 , Pg.1050 , Pg.1051 ]

See also in sourсe #XX -- [ Pg.37 ]

See also in sourсe #XX -- [ Pg.418 , Pg.428 , Pg.429 ]

See also in sourсe #XX -- [ Pg.325 , Pg.326 ]

See also in sourсe #XX -- [ Pg.357 , Pg.374 ]

See also in sourсe #XX -- [ Pg.109 ]

See also in sourсe #XX -- [ Pg.502 , Pg.717 , Pg.747 ]

See also in sourсe #XX -- [ Pg.1468 ]

See also in sourсe #XX -- [ Pg.6 ]

See also in sourсe #XX -- [ Pg.176 ]

See also in sourсe #XX -- [ Pg.139 , Pg.149 , Pg.210 ]

See also in sourсe #XX -- [ Pg.9 , Pg.12 , Pg.13 , Pg.43 , Pg.68 , Pg.175 , Pg.178 , Pg.180 , Pg.202 ]

See also in sourсe #XX -- [ Pg.401 ]

See also in sourсe #XX -- [ Pg.987 ]

See also in sourсe #XX -- [ Pg.565 , Pg.800 ]

See also in sourсe #XX -- [ Pg.165 , Pg.335 , Pg.691 , Pg.765 , Pg.776 , Pg.821 , Pg.837 ]

See also in sourсe #XX -- [ Pg.374 ]

See also in sourсe #XX -- [ Pg.401 ]

See also in sourсe #XX -- [ Pg.1199 ]




SEARCH



A numerical example from the pharmaceutical industry

ABPI: Association of the British Pharmaceutical Industry

Agglomeration in the Pharmaceutical Industry

Allergic pharmaceutical industry

Alternative Solvents in the Pharmaceutical Industry

Alternative solvents pharmaceutical industry

Analgesic agents, pharmaceutical industry

Anti-inflammatory agents, pharmaceutical industry

Anti-malarials, pharmaceutical industry

Antibacterial agents, pharmaceutical industry

Antihelmintics, pharmaceutical industry

Antiviral agents, pharmaceutical industry

Application in Chemical and Pharmaceutical Industries

Application to the Pharmaceutical Industry

Applications Other Than in the Pharmaceutical Industry

Applications of cosolvency in pharmaceutical sciences and industry

Association of British Pharmaceutical Industries

Association of the British Pharmaceutical Industry

Attractions of the Pharmaceutical and Chemical Industries

Beginnings of Modern Pharmaceutical Industry

Behavior pharmaceutical/chemical industries

Biocatalysis for the Pharmaceutical Industry

Biocatalysis for the Pharmaceutical Industry edited by Junhua Tao, Guo-Qiang Lin, and Andreas Liese

Biodiversity: New Leads for the Pharmaceutical and Agrochemical Industries

Biotechnology Industry Pharmaceutical Research

Biotechnology Pharmaceutical industry

CONTAINMENT CHALLENGES AND STRATEGIES FOR POTENT COMPOUNDS IN THE PHARMACEUTICAL INDUSTRY

Challenges of Pharmaceutical Industry Related to Solid Form Selection

Chemical, Petrochemical, and Pharmaceutical Industries

Chromatography in the pharmaceutical industry

Colorants pharmaceutical industry

Continuous Processing in the Pharmaceutical Industry

Cost pressures, pharmaceutical industry

Costs in the pharmaceutical industry

Customer base pharmaceutical industry

Dermatological agents, pharmaceutical industry

Directed metalation, pharmaceutical industry

Discovery toxicology pharmaceutical industry

Diuretics, pharmaceutical industry

Drug Discovery in the Pharmaceutical Industry

Drug development pharmaceutical industry

Drug discovery by the pharmaceutical industry

EFPIA Pharmaceutical Industry

Economics pharmaceutical industry

Education pharmaceutical industry

Ethics pharmaceutical industry

Europe pharmaceutical industry

European Federation Pharmaceutical Industries

European Federation of Pharmaceutical Industries and Associations

European Union pharmaceutical industry

Examples of Enantioseparations in the Pharmaceutical Industry

Extractions in the Pharmaceutical Industry

Fine Chemical and Pharmaceutical Industry

Flavors pharmaceutical industries

Future Trends for Creen Chemistry in the Pharmaceutical Industry

Future of the Pharmaceutical Industry

Geographical Index of the North American Pharmaceutical Industry

German Pharmaceutical Industry

Germany pharmaceutical industry

Global pharmaceutical industry

Good laboratory practice pharmaceutical industry

Green Chemistry in the Pharmaceutical Industry

Heterogeneous Catalysis in the Fine Chemical and Pharmaceutical Industries

High-Throughput Analysis in the Pharmaceutical Industry

History of the pharmaceutical industry

How Computational Chemistry Became Important in the Pharmaceutical Industry

Immunosuppressants, pharmaceutical industry

Importance of Polymorphs and Salts in the Pharmaceutical Industry

Indonesia pharmaceutical industry

Industrial examples Pharmaceutical industry

Industrial pharmaceutical intermediate production

Industrial pharmaceutical technology

Industry Business Unit Pharmaceuticals

Infectious disease pharmaceutical industry

Ion Chromatography in the Pharmaceutical Industry

Japan pharmaceutical industry

Lead optimization pharmaceutical industry applications

Legislation pharmaceutical industry

Local pharmaceutical industry

Massachusetts pharmaceutical industry

Microstructured fine chemical/pharmaceutical industry

Name Index of the North American Pharmaceutical Industry

National Science Foundation pharmaceutical industry

Natural Products and the Pharmaceutical Industry

Neuroleptics, pharmaceutical industry

Nucleus of the Pharmaceutical Industry

Occupational Toxicology in the Pharmaceutical Industry

On-line PAT Applications of Spectroscopy in the Pharmaceutical Industry

Opportunity PHARMACEUTICAL INDUSTRY

Optically pure synthons, biocatalytic pharmaceutical industry

Outsourcing pharmaceutical industry/custom

Patents pharmaceutical industries

Pfizer Pharmaceutical industry

Pharmaceutical Industry Association

Pharmaceutical Industry Australia)

Pharmaceutical Industry Competitiveness

Pharmaceutical Industry Investment Programme

Pharmaceutical Industry Vocabulary

Pharmaceutical and industrial uses

Pharmaceutical companies industry consolidation

Pharmaceutical creams industry

Pharmaceutical development, in industry

Pharmaceutical industries, freeze-drying

Pharmaceutical industries, freeze-drying intensification

Pharmaceutical industry (also

Pharmaceutical industry - introduction

Pharmaceutical industry ABPI Code of Practice

Pharmaceutical industry California

Pharmaceutical industry China

Pharmaceutical industry IFPMA

Pharmaceutical industry India

Pharmaceutical industry Union

Pharmaceutical industry acetylation

Pharmaceutical industry activity

Pharmaceutical industry advances

Pharmaceutical industry advertising

Pharmaceutical industry agencies

Pharmaceutical industry alcohols

Pharmaceutical industry amines

Pharmaceutical industry analgesic

Pharmaceutical industry analytical techniques

Pharmaceutical industry antibiotics

Pharmaceutical industry anticancer drugs

Pharmaceutical industry applications

Pharmaceutical industry applications cyclodextrins

Pharmaceutical industry applications polymorphism

Pharmaceutical industry ascorbic acid

Pharmaceutical industry basic cycle

Pharmaceutical industry benzodiazepines

Pharmaceutical industry business cycle

Pharmaceutical industry characteristics

Pharmaceutical industry characteristics Plastic processes

Pharmaceutical industry characteristics Plastic processing

Pharmaceutical industry characteristics chemical process

Pharmaceutical industry characteristics chemical processing

Pharmaceutical industry characteristics coating

Pharmaceutical industry characteristics drug delivery

Pharmaceutical industry characteristics forms

Pharmaceutical industry characteristics industrial

Pharmaceutical industry characteristics mixing

Pharmaceutical industry characteristics patents

Pharmaceutical industry characteristics profile

Pharmaceutical industry characteristics rheology

Pharmaceutical industry characteristics toxicity

Pharmaceutical industry chemists’ skills

Pharmaceutical industry chiral drug

Pharmaceutical industry chromatography

Pharmaceutical industry clinical trial support

Pharmaceutical industry communication

Pharmaceutical industry companies

Pharmaceutical industry comparator assessment

Pharmaceutical industry compared with other industries

Pharmaceutical industry computers

Pharmaceutical industry consolidation

Pharmaceutical industry contract manufacturer

Pharmaceutical industry core business

Pharmaceutical industry cost containment

Pharmaceutical industry cost containment strategies

Pharmaceutical industry cost-effectiveness

Pharmaceutical industry customers

Pharmaceutical industry definition

Pharmaceutical industry derivatives

Pharmaceutical industry description

Pharmaceutical industry disciplines covered

Pharmaceutical industry diseases

Pharmaceutical industry drug consumption

Pharmaceutical industry drug discovery

Pharmaceutical industry drug discovery phase

Pharmaceutical industry drug discovery process

Pharmaceutical industry drug sources

Pharmaceutical industry drugs

Pharmaceutical industry early history

Pharmaceutical industry economic factors

Pharmaceutical industry enantiopure drugs

Pharmaceutical industry enhancement

Pharmaceutical industry ethanols

Pharmaceutical industry ethical issues

Pharmaceutical industry evolution/structure

Pharmaceutical industry expenditure

Pharmaceutical industry experimental formulations

Pharmaceutical industry facilities

Pharmaceutical industry findings

Pharmaceutical industry future research issues

Pharmaceutical industry future trends

Pharmaceutical industry generics

Pharmaceutical industry global production

Pharmaceutical industry globalization

Pharmaceutical industry imaging

Pharmaceutical industry improvements

Pharmaceutical industry in Africa

Pharmaceutical industry innovation

Pharmaceutical industry innovation tools

Pharmaceutical industry innovator competition

Pharmaceutical industry institutes

Pharmaceutical industry intellectual property rights

Pharmaceutical industry interaction with regulatory

Pharmaceutical industry legal issues

Pharmaceutical industry manufacture

Pharmaceutical industry market

Pharmaceutical industry market structure

Pharmaceutical industry marketing

Pharmaceutical industry mergers

Pharmaceutical industry microbiological fermentation

Pharmaceutical industry monitoring

Pharmaceutical industry objectives

Pharmaceutical industry operation

Pharmaceutical industry opportunities, chemists

Pharmaceutical industry oral dosage forms

Pharmaceutical industry organizational structure

Pharmaceutical industry origins

Pharmaceutical industry outsourcing

Pharmaceutical industry overview

Pharmaceutical industry paclitaxel

Pharmaceutical industry parallel trade

Pharmaceutical industry parenteral dosage forms

Pharmaceutical industry patenting

Pharmaceutical industry penicillin

Pharmaceutical industry pharmacoeconomics

Pharmaceutical industry practitioners

Pharmaceutical industry preparative

Pharmaceutical industry presenter protein properties

Pharmaceutical industry presenting protein strategy

Pharmaceutical industry process cycle

Pharmaceutical industry product cycle

Pharmaceutical industry production

Pharmaceutical industry products

Pharmaceutical industry profits

Pharmaceutical industry progesterone

Pharmaceutical industry quality assurance

Pharmaceutical industry research

Pharmaceutical industry research data

Pharmaceutical industry responsibilities

Pharmaceutical industry riboflavin

Pharmaceutical industry sciences involved

Pharmaceutical industry small molecule ligand affinity

Pharmaceutical industry social factors

Pharmaceutical industry sources

Pharmaceutical industry specific needs

Pharmaceutical industry spermicides

Pharmaceutical industry statistics

Pharmaceutical industry sterile products

Pharmaceutical industry streptomycin

Pharmaceutical industry structure

Pharmaceutical industry surfactant applications

Pharmaceutical industry sustainable innovation

Pharmaceutical industry synthetic steroids

Pharmaceutical industry taxol

Pharmaceutical industry technique hyphenation

Pharmaceutical industry topical drug administration

Pharmaceutical industry toxicity concerns

Pharmaceutical industry trade names

Pharmaceutical industry trade shows

Pharmaceutical industry training needs

Pharmaceutical industry transdermal drug delivery

Pharmaceutical industry trend

Pharmaceutical industry trust

Pharmaceutical industry vinblastine

Pharmaceutical industry vincristine

Pharmaceutical industry voluntary codes

Pharmaceutical industry wastes

Pharmaceutical industry websites

Pharmaceutical industry wide ranging applications

Pharmaceutical industry work statement

Pharmaceutical industry, antidepressants

Pharmaceutical industry, antidepressants marketing

Pharmaceutical industry, biocatalytic

Pharmaceutical industry, biocatalytic pure synthons

Pharmaceutical industry, economic pressure

Pharmaceutical industry, high-performance

Pharmaceutical industry, high-performance liquid chromatography

Pharmaceutical industry, history

Pharmaceutical industry, in India

Pharmaceutical industry, membrane application

Pharmaceutical industry, prescribing

Pharmaceutical industry, prescribing influence

Pharmaceutical industry, protease

Pharmaceutical industry, protease applications

Pharmaceutical industry, regulatory oversight

Pharmaceutical industry, safety

Pharmaceutical industry, safety concerns

Pharmaceutical industry: cost structure

Pharmaceutical industry: cost structure development

Pharmaceutical medicine industrial roles

Pharmaceuticals industrial applications

Pharmaceuticals industrial processing

Pharmaceuticals, industrial fermentation

Pharmacy Pharmaceutical industry

Physicians and the Pharmaceutical Industry

Polymorphism, pharmaceutical industry

Polymorphism, pharmaceutical industry properties

Polymorphism, pharmaceutical industry solid-state characterization

Practice for the Pharmaceutical Industry

Pregnancy outcome pharmaceutical Industry

Primacy of the Pharmaceutical Industry in Drug Discovery and Development

Process Chemistry in the Pharmaceutical Industry Kumar G. Gadamasetti and Ambarish K. Singh

Process Chemistry in the Pharmaceutical Industry, Volume

Process analysis in the pharmaceutical industry

Promotion/information Pharmaceutical Industry

Public attitude pharmaceutical industry

Regulatory agencies pharmaceutical industry

Roller Compaction Technology for the Pharmaceutical Industry Ronald W. Miller and Paul J. Sheskey

Safety assessment pharmaceutical industry

Safety biomarkers pharmaceutical industry

Sales growth, pharmaceutical industry

Selected Examples of Acylation Reactions with Interest for the Pharmaceutical Industry

Shanghai Pharmaceutical Industry Research

Shanghai Pharmaceutical Industry Research Institute

Singapore pharmaceutical industry

Slovakia Association of Chemical and Pharmaceutical Industry

Slovakia Association of Chemical and Pharmaceutical Industry ZCHFP)

Solvents Used in the Pharmaceutical Industry

Specific Needs of the Pharmaceutical Industry

Statisticians in the Pharmaceutical Industry

Structure-activity relationships pharmaceutical industry applications

Swedish Association of the Pharmaceutical Industry

THz Imaging in the Pharmaceutical Industry

Tanzania Pharmaceutical Industries

Teva Pharmaceutical Industries Ltd

The Pharmaceutical Industries and Green Chemistry

The Pharmaceutical Industry

Total Pharmaceutical Industry Returns

Traceability without uncertainty current situation in pharmaceutical industry

United Kingdom Pharmaceutical Industry

United States pharmaceutical industry

Use of Cyclodextrins in Food, Pharmaceutical and Cosmetic Industries

Vitamins pharmaceutical industry

Water for foodstuff and pharmaceutical industries

© 2019 chempedia.info